Clinical evidence

Clinical studies have proven RESET and RESET-O to be effective in helping improve outcomes in patients with substance use disorder (SUD) and opioid use disorder (OUD).1,2

 

RESET is used to treat SUD as an adjunct to outpatient therapy.

In a 12-week study of RESET:1

RESET-O is used to treat OUD as an adjunct to outpatient therapy that includes transmucosal buprenorphine.

In a 12-week study of RESET-O:2

References:

1. RESET-O Clinician directions for use. Pear Therapeutics, Inc. 2020.

2. RESET Clinician directions for use. Pear Therapeutics, Inc. 2020.

3. FDA permits marketing of mobile medical application for substance use disorder. News release. Silver Spring, MD: US Food and Drug Administration. September 14, 2017. Accessed May 18, 2020. https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-mobile-medical-application-substance-use-disorder

4. FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs. News release. Silver Spring, MD: US Food and Drug Administration. December 10, 2018. Accessed May 18, 2020. https://www.fda.gov/news-events/press-announcements/fda-clears-mobile-medical-app-help-those-opioid-use-disorder-stay-recovery-programs